中银创新医疗混合C(010500)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-100,646,398.27 |
1,932,103,313.59 |
1,732,800,818.36 |
-291,790,447.49 |
| 利息合计 |
207,555.62 |
341,425.26 |
160,089.42 |
316,011.61 |
| 其中:存款利息收入 |
184,528.48 |
341,425.26 |
160,089.42 |
316,011.61 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
23,027.14 |
- |
- |
- |
| 投资收益合计 |
402,072,294.52 |
1,197,801,516.50 |
711,678,322.10 |
-156,982,716.53 |
| 其中:股票投资收益 |
397,966,629.93 |
1,185,100,329.25 |
705,562,754.99 |
-165,744,718.88 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
1,083,369.64 |
2,454,145.30 |
857,882.73 |
2,376,057.61 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
3,022,294.95 |
10,247,041.95 |
5,257,684.38 |
6,385,944.74 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-507,609,974.78 |
705,247,022.54 |
1,004,635,298.75 |
-137,204,687.92 |
| 其他收入 |
4,683,726.37 |
28,713,349.29 |
16,327,108.09 |
2,080,945.35 |
| 费用 |
21,368,143.82 |
66,227,106.01 |
28,265,815.15 |
38,058,748.84 |
| 管理人报酬 |
16,321,357.19 |
49,910,207.76 |
21,514,388.19 |
29,690,896.18 |
| 基金托管费 |
2,720,226.18 |
8,318,368.04 |
3,585,731.39 |
4,948,482.79 |
| 销售服务费 |
2,170,369.81 |
7,630,187.96 |
2,991,909.03 |
3,122,626.50 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
155,866.60 |
368,342.25 |
173,786.54 |
296,743.37 |
| 利润总额 |
-122,014,542.09 |
1,865,876,207.58 |
1,704,535,003.21 |
-329,849,196.33 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年